FRAME Scientific Liaison Officer Amy Beale discusses the issue and consequences of poor reproducibility in animal research and why reproducibility needs to become a priority for
Today (28 July 2020) marks World Hepatitis Day, which aims to raise global awareness of hepatitis – a group of infectious diseases which affect millions of people worldwide.
The Home Office has published the Annual Statistics of Scientific Procedures on Living Animals in Great Britain 2019, showing that 3.4 million animal tests were carried out in the UK
The FRAME Alternatives Laboratory has collaborated with the University of Helsinki to investigate the effect of one commonly used drug on gut microbiota and gene expression in IBS
The FRAME Alternatives Laboratory (FAL) has developed an in vitro model to study fatty liver disease associated with chemotherapy.
The global study commissioned by FRAME has revealed that 93.4% of people think more needs to be done to replace and reduce the use of animals in testing and research.
New research underway at the FRAME Alternatives Laboratory in Nottingham is focused on the development of insulin resistance in skeletal muscle (one of the first and most significant
Dr Carol Treasure, the Founder and CEO of specialist animal-free contract testing laboratory XCellR8, has joined FRAME’s Board of Trustees.
FRAME’s international, peer-reviewed scientific journal ATLA (Alternatives to Laboratory Animals), has appointed a new editor-in-chief.
A paper recently published in Regulatory Toxicology and Pharmacology has highlighted opportunities to use one rather than two species for long-term toxicity testing.